<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260512069371N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-09</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of family empowerment on suicidal thoughts and recurrence</public_title>
      <acronym></acronym>
      <scientific_title>The effect of intervention family empowerment on the severity of suicidal thoughts and recurrence of attempted suicide in acting teenagers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90152</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Education/Guidance, Randomization description: "This study will use a block randomization method with variable block sizes (4 and 6). The randomization unit was the individual (each patient). Randomization will be stratified by gender (male/female) and disease severity (mild/moderate/severe). The randomization sequence will be determined using the website.sealedenvelope. For allocation concealment, opaque, sealed, and sequentially numbered envelopes will be used. The allocation sequence is hidden from the investigator. The envelopes will be opened by someone independent of the principal investigator. The quasi-randomization method was not used in this study.".</study_design>
      <phase>3</phase>
      <hc_freetext>suicide.</hc_freetext>
      <i_freetext>Intervention 1: After the research units of the intervention group were determined, the researcher made the necessary coordination with the respected supervisor to hold the date and time of the meetings and informed them on the Yes channel. And by creating a survey to check the presence of caregivers the night before, the date and time of the meetings were finalized. Family empowerment sessions were held every other day for two weeks, with 3 45-minute sessions each week in the classroom of the pediatric ward of Ibn Sina Teaching Hospital. During the empowerment sessions, exercises were included in some sessions that the research units were required to do, and the assignments were explained in person in the next session, and the caregivers were discussed about the assignment and its feedback.It should be noted that the content of the sessions was summarized in the Yes channel related to the group after the end of each session. Content of the sessions: Session 1: Coping with the phenomenon of suicide by caregivers, self-care b) What should I tell people? Session 2: Safety planning for suicidal concerns Session 3: Crisis prevention planning Session 4: Behavior modification Session 5: Review and summary of the material. Intervention 2: Control group: Control group: After the research units were identified, training related to medication use and side effects was provided to the group. At the end of the period, empowerment training will be provided to the family.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information and results will be provided anonymously.

When:
Access period starts 6 months after results are published.

To whom:
The data will be available to researchers working in academic and scientific institutions.

Conditions:
Submit a written request to the principal investigator along with a formal letter of introduction and research proposal approved by the ethics committee. Permitted analyses include secondary analyses related to valid scientific purposes. Non-commercial use and attribution of the original source are required. Data will be provided in an anonymized form only. Requests will be reviewed by the research team and, if approved, will be delivered after signing a data confidentiality agreement.

Where to obtain:
They can first email the corresponding author, Dr. Fatemeh Rajab Dizavandi, or the student, Mohaddeseh Hassanzadeh.
Corresponding author email: rajabf2020@gmail.com
Student email: mohaddesehhasanzadeh92@gmail.com

How to obtain:
By sending an email to the responsible author or the relevant student, the file and data information will be received in less than a week, depending on the country's conditions.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Rajab Dizavandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad University of Medical Sciences, Kharazmi Complex, Faculty of Nursing</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3884 6732</telephone>
        <email>rajabf2020@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Rajab Dizavandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad University of Medical Sciences, Kharazmi Complex, Faculty of Nursing</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3884 6732</telephone>
        <email>rajabf2020@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adolescents: 1-At least one suicide attempt
2-Admission to Ibn Sina Hospital
3-Living with at least one family member permanently
4-Residing in the city and not facing legal prosecution
5-Being literate
family: 1- Be literate
2- Have not participated in previous empowerment and training courses
3- Do not have any DSM-5 disorders
4- Do not have any life-threatening or disabling physical disorders
5- Be over 18 years old and under 65 years old</inclusion_criteria>
      <agemin>13 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Adolescents: Severe mental disability
family: participating in empowerment and other training courses
Behavioral disturbance, evidence of prior psychosis
Participate in other empowerment and training courses
Severe mental disability that impairs the ability to understand informed consent</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>After the research units of the intervention group were determined, the researcher made the necessary coordination with the respected supervisor to hold the date and time of the meetings and informed them on the Yes channel. And by creating a survey to check the presence of caregivers the night before, the date and time of the meetings were finalized. Family empowerment sessions were held every other day for two weeks, with 3 45-minute sessions each week in the classroom of the pediatric ward of Ibn Sina Teaching Hospital. During the empowerment sessions, exercises were included in some sessions that the research units were required to do, and the assignments were explained in person in the next session, and the caregivers were discussed about the assignment and its feedback.It should be noted that the content of the sessions was summarized in the Yes channel related to the group after the end of each session. Content of the sessions: Session 1: Coping with the phenomenon of suicide by caregivers, self-care b) What should I tell people? Session 2: Safety planning for suicidal concerns Session 3: Crisis prevention planning Session 4: Behavior modification Session 5: Review and summary of the material.</i_keyword>
      <i_keyword>Control group: Control group: After the research units were identified, training related to medication use and side effects was provided to the group. At the end of the period, empowerment training will be provided to the family.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of suicidal ideation score based on the Beck Scale for Suicidal Ideation (BSSI), which has a minimum score of 0 and a maximum score of 38. A higher score indicates greater severity of suicidal ideation. Timepoint: Both groups will receive the Beck Suicidality Scale (BSSI) questionnaire, demographic information questionnaire, and Family Empowerment Scale (FES) in the pre-test phase, and the Beck Suicidality Scale and Family Empowerment Scale in the post-test phase (one month after training). Method of measurement: Beck Suicidal Thought Questionnaire and Family Empowerment Questionnaire.</prim_outcome>
      <prim_outcome>Number of suicide attempts during the two-month follow-up period (number of times the adolescent attempts suicide again that requires hospitalization or emergency room visit). Timepoint: After a two-month period of family empowerment, we will check for repeated suicide attempts by calling the family and reviewing the hospital's list. Method of measurement: Using a phone call to family.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-28</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Mashhad University of Medical Sciences, Kharazmi Complex, Faculty of Nursing Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
